Inside Precision Medicine April 1, 2025
In the fast-evolving world of genetic innovation, few leaders embody the spirit of discovery and application like Brad Ringeisen, PhD, executive director of the Innovative Genomics Institute (IGI), does. With a rich career that includes groundbreaking work at the Defense Advanced Research Projects Agency (DARPA), where he spearheaded projects at the intersection of biology and national security, Ringeisen now leads IGI’s mission to harness CRISPR and other cutting-edge technologies to tackle some of humanity’s greatest challenges. In this exclusive interview, Ringeisen shares insights into his transformative vision for the use of advanced genome engineering as personalized medicine worldwide.
This interview has been edited for length and clarity.
Q: What has the IGI set out to accomplish using CRISPR-based gene editing...
Today's Sponsors
Today's Sponsor